Kathleen Laporte - Mar 24, 2022 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role: Director
Signature: /s/ William P. Quinn, Attorney-in-Fact
Stock symbol: BOLT
Transactions as of: Mar 24, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/28/2022, 03:22 PM
Previous filing: Jan 13, 2022
Next filing: May 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BOLT	Stock Option (Right to Buy)	Award	$0	+25K		$0.00	25K	Mar 24, 2022	Common Stock	25K	$3.03	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.

Content

The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.